Claritev (CTEV) Stock: Buy, Sell, or Hold?
CTEV - Claritev Corporation
$23.72
2.41 (11.31%)
▲
5d:
+2.24%
30d:
-41.04%
90d:
-28.47%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 06, 2026
Get Alerted When CTEV Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CTEV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: CTEV shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$55.67
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$34.57
31.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: CTEV is currently trading at $23.72, which is considered oversold relative to its 30-day fair value range of $25.71 to $39.15. From a valuation perspective, the stock is trading at a discount (Forward PE: 3.2) compared to its historical average (3.9). Remarkably, the market is currently pricing in an annual earnings decline of 5.8% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, CTEV is in a uptrend. Immediate support is located at $20.24, while resistance sits at $33.31. The stock is showing strong short-term momentum, up 11.3% recently.
Market Sentiment: CTEV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $46.00 (+93.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CTEV is in a uptrend. Immediate support is located at $20.24, while resistance sits at $33.31. The stock is showing strong short-term momentum, up 11.3% recently.
Market Sentiment: CTEV scores 60/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $46.00 (+93.9%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$25.71 -
$39.15
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
95.2%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+11.3%)
- BULLISH: Trading 93.9% below Wall St target ($46.00)
- CAUTION: Bottoming setup, but lagging the sector by 53% over 20 days — wait for relative strength
Trading Range Analysis
30-Day Trading Range
$25.71 -
$39.15
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$20.24
Resistance Level
$33.31
Current Trend
Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.24
Wall Street Target
$46.00
(+93.9%)
Revenue Growth (YoY)
6.6%
Profit Margin
-28.5%
Valuation Discount vs History
-5.8% cheaper
PE vs Historical
3.2 vs 3.9
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-5.8%
(market-implied from PE analysis)
1-Year Target
$22.34
(-6%)
2-Year Target
$21.05
(-11%)
3-Year Target
$19.83
(-16%)
3-Yr Target (if PE normalizes)
(PE: 3→4)
$23.90
(+1%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 26.2%)
$300.27
(+1166%)
Base:
(SPY PE: 3.2, Growth: 26.2%)
$47.63
(+101%)
Bear:
(PE: 2.8, Growth: 26.2%)
$40.49
(+71%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 3.2 to 3.9
Stabilization Target:
$28.59
(+20.5%)
PE Expansion Potential:
+20.5%
Share & Embed Analysis
Last updated: October 03, 2026 7:01 PM ET
Data refreshes hourly during market hours. Next update: 8:01 PM
Data refreshes hourly during market hours. Next update: 8:01 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTEV showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Health Information Services Stocks
Top-rated stocks in Health Information Services by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
PRVA
Privia Health Group Inc |
STRONG BUY
21 analysts |
$31 | 67 BUY |
|
VEEV
Veeva Systems Inc Class A |
BUY
32 analysts |
$297 | 37 SELL |
|
PHR
Phreesia Inc |
STRONG BUY
15 analysts |
$14 | 69 BUY |
|
GEHC
GE HealthCare Technologi… |
STRONG BUY
21 analysts |
$90 | 60 BUY |
|
EVH
Evolent Health Inc |
STRONG BUY
14 analysts |
$6 | 54 HOLD |
